Tag:
Otelixizumab
Latest Headlines
Latest Headlines
GSK, Tolerx diabetes drug flunks PhIII
GlaxoSmithKline and partner Tolerx were dealt a blow as their drug otelixizumab failed a late-stage trial. The drug, a humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy
